Showing 1 - 10 of 8,149
The object of research is investment and innovation activity as a component of modern medical management. One of the problematic points is that the transformational transition from outdated management methods has caused the need to form a new management system, which should be implemented in all...
Persistent link: https://www.econbiz.de/10013226616
Underrepresentation of minority and poor households in scientific studies undermines policy decisions and public health. We study data from a serological study that randomized participation incentives. Participation is low (6% at $0, 17% at $100, 29% at $500) and unequal: minority and poor...
Persistent link: https://www.econbiz.de/10013537774
The Belgian pharmaceutical sector has been accorded a leading role in the attainment of the R&D investment targets which the EU Member States set themselves as part of the Lisbon strategy. To gain a better insight into that sector's research activities, the NBB conducted an ad hoc survey in...
Persistent link: https://www.econbiz.de/10011618278
Background Health science is evolving extremely rapidly at worldwide level. There is a large volume of articles about health economics that are published each year. The main purpose of this research is to explore health economics in the world's scholarly literature based on a scient metric...
Persistent link: https://www.econbiz.de/10014500364
This paper - written for an edited volume addressing how law and policy can keep pace with highly dynamic scientific and technological innovation - proposes an international framework to coordinate and facilitate national responses to innovations that may create significant risks or pose social,...
Persistent link: https://www.econbiz.de/10013095869
Innovation policy can be a crucial component of governments' responses to crises. Because speed is a paramount objective, crisis innovation may also require different policy tools than innovation policy in non-crisis times, raising distinct questions and tradeoffs. In this paper, we survey the...
Persistent link: https://www.econbiz.de/10013216371
Persistent link: https://www.econbiz.de/10009529790
The Belgian pharmaceutical sector has been accorded a leading role in the attainment of the R&D investment targets which the EU Member States set themselves as part of the Lisbon strategy. To gain a better insight into that sector’s research activities, the NBB conducted an ad hoc survey in...
Persistent link: https://www.econbiz.de/10011506627
Persistent link: https://www.econbiz.de/10000063816